Aveo Pharmaceuticals (AVEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -107,029 | -90,304 | -65,998 | -34,085 | -114,394 |
| Depreciation Amortization | 4,816 | 3,709 | 2,545 | 1,239 | 4,956 |
| Accounts receivable | 19,665 | 11,756 | 12,752 | 11,468 | -13,439 |
| Accounts payable and accrued liabilities | -6,390 | -4,491 | -3,398 | -2,545 | 1,724 |
| Other Working Capital | 13,438 | 7,319 | 7,701 | 8,519 | -4,720 |
| Other Operating Activity | -8,902 | -3,736 | -7,078 | -6,204 | 20,144 |
| Operating Cash Flow | $-84,402 | $-75,747 | $-53,476 | $-21,608 | $-105,729 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 15,738 | 3,656 | -38,596 | -21,600 | 145,195 |
| PPE Investments | -3,668 | -3,011 | -1,975 | -762 | -9,948 |
| Investing Cash Flow | $12,070 | $645 | $-40,571 | $-22,362 | $135,247 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 3,672 |
| Debt Repayment | -7,104 | -4,660 | -2,294 | N/A | -2,172 |
| Common Stock Issued | 54,102 | 54,022 | 54,003 | 53,708 | 1,636 |
| Financing Cash Flow | $46,998 | $49,362 | $51,709 | $53,708 | $3,136 |
| Exchange Rate Effect | 26 | 26 | 26 | 26 | -26 |
| Beginning Cash Position | 76,134 | 76,134 | 76,134 | 76,134 | 43,506 |
| End Cash Position | 50,826 | 50,420 | 33,822 | 85,898 | 76,134 |
| Net Cash Flow | $-25,308 | $-25,714 | $-42,312 | $9,764 | $32,628 |
| Free Cash Flow | |||||
| Operating Cash Flow | -84,402 | -75,747 | -53,476 | -21,608 | -105,729 |
| Capital Expenditure | -3,668 | -3,011 | -1,975 | -762 | -9,948 |
| Free Cash Flow | -88,070 | -78,758 | -55,451 | -22,370 | -115,677 |